The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication
- PMID: 16754840
- PMCID: PMC1924721
- DOI: 10.1001/archpsyc.63.6.669
The prevalence and correlates of DSM-IV intermittent explosive disorder in the National Comorbidity Survey Replication
Abstract
Context: Little is known about the epidemiology of intermittent explosive disorder (IED).
Objective: To present nationally representative data on the prevalence and correlates of DSM-IV IED.
Design: The World Health Organization Composite International Diagnostic Interview was used to assess DSM-IV anxiety disorders, mood disorders, substance use disorders, and impulse control disorders.
Setting: The National Comorbidity Survey Replication, a face-to-face household survey carried out in 2001-2003.
Participants: A nationally representative sample of 9282 people 18 years and older.
Main outcome measure: Diagnoses of DSM-IV IED.
Results: Lifetime and 12-month prevalence estimates of DSM-IV IED were 7.3% and 3.9%, with a mean 43 lifetime attacks resulting in 1359 dollars in property damage. Intermittent explosive disorder-related injuries occurred 180 times per 100 lifetime cases. Mean age at onset was 14 years. Sociodemographic correlates were uniformly weak. Intermittent explosive disorder was significantly comorbid with most DSM-IV mood, anxiety, and substance disorders. Although the majority of people with IED (60.3%) obtained professional treatment for emotional or substance problems at some time in their life, only 28.8% ever received treatment for their anger, while only 11.7% of 12-month cases received treatment for their anger in the 12 months before interview.
Conclusions: Intermittent explosive disorder is a much more common condition than previously recognized. The early age at onset, significant associations with comorbid mental disorders that have later ages at onset, and low proportion of cases in treatment all make IED a promising target for early detection, outreach, and treatment.
Figures
Comment in
-
Intermittent explosive disorder is common, has an early age of onset and is associated with the development of other mental disorders in the US population.Evid Based Ment Health. 2007 Feb;10(1):32. doi: 10.1136/ebmh.10.1.32. Evid Based Ment Health. 2007. PMID: 17255401 No abstract available.
Similar articles
-
Intermittent explosive disorder in the National Comorbidity Survey Replication Adolescent Supplement.Arch Gen Psychiatry. 2012 Nov;69(11):1131-9. doi: 10.1001/archgenpsychiatry.2012.592. Arch Gen Psychiatry. 2012. PMID: 22752056 Free PMC article.
-
Prevalence and clinical correlates of intermittent explosive disorder in Turkish psychiatric outpatients.Compr Psychiatry. 2018 May;83:64-70. doi: 10.1016/j.comppsych.2018.03.003. Epub 2018 Mar 18. Compr Psychiatry. 2018. PMID: 29604524
-
The cross-national epidemiology of DSM-IV intermittent explosive disorder.Psychol Med. 2016 Nov;46(15):3161-3172. doi: 10.1017/S0033291716001859. Epub 2016 Aug 30. Psychol Med. 2016. PMID: 27572872 Free PMC article.
-
[Intermittent explosive disorder: current status].Encephale. 2007 May-Jun;33(3 Pt 1):339-45. doi: 10.1016/s0013-7006(07)92048-5. Encephale. 2007. PMID: 17675932 Review. French.
-
Intermittent explosive disorder: epidemiology, diagnosis and management.CNS Drugs. 2002;16(8):517-26. doi: 10.2165/00023210-200216080-00002. CNS Drugs. 2002. PMID: 12096933 Review.
Cited by
-
Possible roles of neuropeptide/transmitter and autoantibody modulation in emotional problems and aggression.Front Psychiatry. 2024 Sep 24;15:1419574. doi: 10.3389/fpsyt.2024.1419574. eCollection 2024. Front Psychiatry. 2024. PMID: 39381606 Free PMC article. Review.
-
Psychiatric, Neurological, and Somatic Comorbidities in Intermittent Explosive Disorder: a retrospective cohort study of electronic health records.medRxiv [Preprint]. 2024 Sep 13:2024.09.12.24313553. doi: 10.1101/2024.09.12.24313553. medRxiv. 2024. PMID: 39314972 Free PMC article. Preprint.
-
Personality Disorder Symptoms in Intermittent Explosive Disorder: A Latent Class Analysis.J Pers Disord. 2024 Feb;38(1):34-52. doi: 10.1521/pedi.2024.38.1.34. J Pers Disord. 2024. PMID: 38324246 Free PMC article.
-
A systematic review with meta-analysis of cognitive bias modification interventions for anger and aggression.Behav Res Ther. 2023 Aug;167:104344. doi: 10.1016/j.brat.2023.104344. Epub 2023 Jun 2. Behav Res Ther. 2023. PMID: 37307657 Free PMC article.
-
Prevalence and correlates of DSM-IV and DSM-5 Intermittent Explosive Disorder amongst Myanmar refugees living in Malaysia: a population-based study.Epidemiol Psychiatr Sci. 2022 Aug 15;31:e57. doi: 10.1017/S2045796022000257. Epidemiol Psychiatr Sci. 2022. PMID: 35968549 Free PMC article.
References
-
- Coccaro EF, Kavoussi RJ, Berman ME, Lish JD. Intermittent explosive disorder-revised: development, reliability, and validity of research criteria. Compr Psychiatry. 1998;39:368–376. - PubMed
-
- Coccaro EF, Schmidt CA, Samuels JF, Nestadt G. Lifetime and 1-month prevalence rates of intermittent explosive disorder in a community sample. J Clin Psychiatry. 2004;65:820–824. - PubMed
-
- Posternak MA, Zimmerman M. Anger and aggression in psychiatric outpatients. J Clin Psychiatry. 2002;63:665–672. - PubMed
-
- Kessler RC, Berglund P, Demler O, Jin R, Koretz D, Merikangas KR, Rush AJ, Walters EE, Wang PS. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R) JAMA. 2003;289:3095–3105. - PubMed
Publication types
MeSH terms
Grants and funding
- R13 MH066849-03/MH/NIMH NIH HHS/United States
- R03 TW006481-02S1/TW/FIC NIH HHS/United States
- R01 DA016558/DA/NIDA NIH HHS/United States
- R01 DA016558-02/DA/NIDA NIH HHS/United States
- U01-MH60220/MH/NIMH NIH HHS/United States
- R03 TW006481/TW/FIC NIH HHS/United States
- R01 MH069864/MH/NIMH NIH HHS/United States
- K05 DA015799/DA/NIDA NIH HHS/United States
- U01 MH060220/MH/NIMH NIH HHS/United States
- R01 MH069864-02/MH/NIMH NIH HHS/United States
- R01 MH070884/MH/NIMH NIH HHS/United States
- R01 MH070884-01A2/MH/NIMH NIH HHS/United States
- U01 MH060220-05/MH/NIMH NIH HHS/United States
- U13 MH066849/MH/NIMH NIH HHS/United States
- R13 MH066849/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
